Murder, suicide, car crashes, and addiction have all contributed to a spike in deaths among U.S. children and teens in recent years, a government study suggests.
Amygdala Neurosciences has agreed to acquire Gilead’s GS-6637, a highly selective ALDH2 inhibitor with the potential to treat behavior and substance addictions.
Partnership for Drug-Free Kids announced the national launch of “Search and Rescue,” a prescriber education campaign that gives healthcare providers the resources they need to prescribe opioids responsibly and prevent the misuse and abuse of medicine in their practices.
A form of “virtual reality” therapy might help treat alcohol addiction, suggests a preliminary study from South Korea. The study involved only 10 patients with alcohol dependence. But senior researcher Dr. Doug Hyun Han of Chung-Ang University Hospital in Seoul and colleagues think the approach might be promising, in part because it puts patients in […]
As the medical community continues searching for ways to curb opioid-related deaths through treatment and management, the pharmaceutical industry proceeds with pushing for naloxone, a generic drug also known as Narcan – and the results are paying off. A new Morbidity and Mortality Weekly Report (MMWR) published by the Centers for Disease Control and Prevention (CDC) revealed that naloxone kits […]
AUSTIN, Texas — Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind — […]